drugset / Trial / NCT01474499

A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation

NCT01474499

Phase 3 Completed 300 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to evaluate the efficacy and safety of the docusate sodium and sorbitol rectal solution produced by Ferring Pharmaceutical (China) Ltd. in treating Chinese patients with constipation.

Timeline

Start
2011-09
Primary completion
2012-03
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Docusate Sodium Unknown Rectal
Comparator Glycerin Other / unclassified Rectal
Subject Sorbitol Small molecule Rectal

Indications